<DOC>
	<DOC>NCT02278354</DOC>
	<brief_summary>Subjects enrolled in the Professional Fighters Brain Health Study (PFBHS) will receive 18F-AV-1451 to explore its use as a biomarker for brain injury related to repetitive head trauma and to examine the relationship between clinical presentation and tau deposition.</brief_summary>
	<brief_title>Tau Imaging in Professional Fighters</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>All Subjects Currently enrolled in the PFBHS protocol and have participated in a minimum of 10 professional fights Can tolerate Positron Emission Tomography (PET) scan procedures Have the ability to provide informed consent Subjects with cognitive impairment Have subjective cognitive complaints or objective decline or impairment as determined by the investigator Have behavior dysfunction that is likely to interfere with imaging Are claustrophobic or otherwise unable to tolerate the imaging procedure Have current clinically significant cardiovascular disease or clinically significant abnormalities on screening electrocardiogram A history of additional risk factors for Torsades de Pointes (TdP) or are taking drugs that are known to cause QTprolongation Have a current clinically significant infectious disease, endocrine or metabolic disease, pulmonary, renal or hepatic impairment, or cancer Have had a nonstudy related radiopharmaceutical imaging or treatment procedure within 7 days prior to the study imaging session Have current drug or alcohol dependence or alcohol dependence within the past 2 years</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>